ACKERMAN RICHARD (President and CEO) sold 87.0% of their position (1.50M shares) of NRX PHARMACEUTICALS, INC. on the open market
Insider sale on the open market — a major position exit. Check remaining position size for full context.
S · 1 sale
Filed: 11/20/2018ACC: 0001654954-18-013065
DirectorOfficer· President and CEO
Since Nov 2018
-1.50M
Net shares
Net seller
$0.00
Total acquired
1
Open market trades
0B · 1S
1
Total transactions
1.50M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−1.50M
Price / share
—
Trade value
—
% of position
87.0%
11/20/2018
1.73M→225K
Total
Net shares
−1.50M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/20/2018 | S · Sale | −1.50M | — | — | 87.0% | 1.73M | 225K |
| Total | −1.50M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned272.50K
Total
272.50K indirect272.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 272.50K | Indirect |
| Total | 272.50K | 272.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported